Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TISLELIZUMAB-JSGR Cause Anaemia? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Anaemia have been filed in association with TISLELIZUMAB-JSGR. This represents 16.0% of all adverse event reports for TISLELIZUMAB-JSGR.

8
Reports of Anaemia with TISLELIZUMAB-JSGR
16.0%
of all TISLELIZUMAB-JSGR reports
1
Deaths
1
Hospitalizations

How Dangerous Is Anaemia From TISLELIZUMAB-JSGR?

Of the 8 reports, 1 (12.5%) resulted in death, 1 (12.5%) required hospitalization, and 1 (12.5%) were considered life-threatening.

Is Anaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TISLELIZUMAB-JSGR. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does TISLELIZUMAB-JSGR Cause?

Disease progression (15) Off label use (9) Pneumonia (8) Lymphadenopathy (7) Thrombocytopenia (7) Infusion related reaction (6) Pyrexia (6) Death (5)

What Other Drugs Cause Anaemia?

LENALIDOMIDE (5,322) CARBOPLATIN (5,312) RIBAVIRIN (5,130) ASPIRIN (4,568) CYCLOPHOSPHAMIDE (4,486) RITUXIMAB (4,399) DEXAMETHASONE (4,352) ADALIMUMAB (3,994) PACLITAXEL (3,949) METHOTREXATE (3,913)

Related Pages

TISLELIZUMAB-JSGR Full Profile All Anaemia Reports All Drugs Causing Anaemia TISLELIZUMAB-JSGR Demographics